Presentation TCT 2017 Case Presentation: Management of a Major SFA Dissection Presenter: Michael Guiry, Julie Logan, Herbert D. Aronow October 30, 2017
Presentation TCT 2017 Case Presentations: Retrograde Approaches to Chronic Total Occlusions (With Discussion) Presenter: Philippe Genereux, Simon J. Walsh, Michael Luna October 30, 2017
Presentation TCT 2017 The Alphabet of Peripheral Vascular Devices: BMS, DES, PTFE, BVS, and Future Scaffolds Presenter: Michael Guiry, Julie Logan October 30, 2017
Presentation TCT 2017 Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms Presenter: Dariusz Dudek, Martin Hudec, Michael Haude October 30, 2017
Presentation TCT 2017 Research Opportunities in PE Therapy Presenter: Michael R. Jaff, Robert A. Lookstein October 30, 2017
Presentation TCT 2017 Techniques and Outcomes of PE Lysis: Is Catheter-Directed Thrombolysis Really Better Than IV Lytics? Presenter: Michael R. Jaff, Robert A. Lookstein, Jay S. Giri October 30, 2017
Presentation TCT 2017 Is PE Really a Team Sport? Benefits and Disadvantages of PERT Presenter: Michael R. Jaff, Robert A. Lookstein, Kenneth Rosenfield October 30, 2017
Presentation TCT 2017 Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients? Presenter: C. Michael Gibson, Stephan Windecker October 30, 2017
Presentation TCT 2017 Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds? Presenter: C. Michael Gibson, Stephan Windecker, Stephan Achenbach October 30, 2017
Presentation TCT 2017 Optimal Techniques for Catheter-Directed Thrombolysis Presenter: Michael R. Jaff, Robert A. Lookstein October 30, 2017
Presentation TCT 2017 Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy? Presenter: C. Michael Gibson, Stephan Windecker, Eric R. Bates October 30, 2017
Presentation TCT 2017 Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI? Presenter: C. Michael Gibson, Stephan Windecker, David Hildick-Smith October 30, 2017
Presentation TCT 2017 Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI Presenter: Grzegorz L. Kaluza, Jose M. Wiley, Michael C. Kim October 29, 2017
Presentation TCT 2017 Surgical Repair vs Replacement for Severe Secondary MR Presenter: Jeroen J. Bax, Stephan Windecker, Michael A. Borger October 29, 2017
Presentation TCT 2017 Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Anthony H. Gershlick October 29, 2017
Presentation TCT 2017 Debate: Revascularization of Left Main Disease - CABG Remains Standard of Care Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker October 29, 2017
Presentation TCT 2017 Debate: Revascularization of Left Main Disease - PCI Should Be Preferred in EXCEL-Like Patients Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Adrian P. Banning October 29, 2017
Presentation TVT 2017 The Rationale and Need for a Tiered National System of Valve Centers Controversies and Proposed Programs Presenter: Robert O. Bonow, Martin B. Leon, Michael J. Mack June 15, 2017
Presentation TVT 2017 Combination Transcatheter Mitral Valve Interventions and LAA Occlusion Clinical and Technical Considerations Presenter: Michael J. Mack, Fabian Nietlispach June 15, 2017
Presentation TVT 2017 A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR) Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack June 15, 2017